
Search
Filter Results
Displaying 201–210 of 664 for “retinitis clinical trial”
-
May 4, 2020
#GivingTuesdayNow Featured Researcher Dr. Shannon Boye
A Lifelong Science Nerd is Winning the Fight Against Blindness
-
Jan 19, 2017
Foundation Investing in Drug to Slow Many Forms of RP
The Foundation Fighting Blindness Clinical Research Institute (FFB-CRI) has announced an investment of up to $7.5 million to advance the potential therapy into and through a Phase II clinical trial.
-
Jun 24, 2016
A Steady Hand in Saving Vision
Subretinal injection is the most common form of delivery for gene therapies currently in clinical trials.
-
May 3, 2016
ARVO 2016: What Does It Take to Develop a Stem-Cell Therapy for the Retina?
There are innumerable considerations for researchers developing therapies.
-
Oct 29, 2014
Low-Hanging Fruit: Repurposing Drugs to Treat Retinal Diseases
Because repurposing relies on prior research and clinical data, it reduces the cost and time needed to establish a new therapeutic application for the drug.
-
Dec 18, 2012
Curing Blindness, Part 1: Corey’s Story
How gene therapy restored some of a boy’s sight.
-
Feb 4, 2025
The free, online event at 7 p.m. ET on March 13, 2025, will feature presentations from Christine Kay, MD, Vitreoretinal Associates in Gainesville, Florida, and Thomas Mendel, MD, PhD, Ohio State University Wexner Medical Center.
-
Apr 26, 2021
SparingVision to Acquire Therapy for Resurrecting Dormant Cones for Vision Restoration
The gene-agnostic approach shows promise for people with late-stage RP and related diseases.
-
May 13, 2020
jCyte Enters into Licensing Agreement with Santen Pharmaceutical for Cell Therapy
Emerging treatment designed to preserve vision for people with RP and related conditions
-
Jul 9, 2019
SparingVision Gets EU Funding Boost for Development of Cross-Cutting Gene Therapy
A clinical trial for the treatment, designed to preserve cone photoreceptors, is planned in the US and Europe in 2020.